Andrew Ambrosy to Predictive Value of Tests
This is a "connection" page, showing publications Andrew Ambrosy has written about Predictive Value of Tests.
Connection Strength
0.527
-
Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. Circ Heart Fail. 2016 05; 9(5).
Score: 0.125
-
The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry. Eur Heart J Acute Cardiovasc Care. 2013 Jun; 2(2):99-108.
Score: 0.102
-
Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail. 2012 Mar; 14(3):302-11.
Score: 0.094
-
Acute heart failure syndromes: assessment and reconstructing the heart. J Cardiovasc Med (Hagerstown). 2011 Apr; 12(4):258-63.
Score: 0.088
-
A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF). J Cardiovasc Transl Res. 2020 08; 13(4):540-548.
Score: 0.040
-
Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. Am J Cardiol. 2016 Apr 01; 117(7):1144-50.
Score: 0.031
-
Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2012 Nov; 5(6):750-8.
Score: 0.024
-
Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med (Hagerstown). 2011 Jul; 12(7):460-8.
Score: 0.022